Limit on Embryo Use Asked

COPENHAGEN-The use of human embryos in industry should be banned and their use in therapeutic and scientific work strongly regulated, the Parliamentary Assembly of the Council of Europe has recommended to its 22 members. Its recommendation, approved Sept. 25, calls on European governments to forbid "the maintenance of embryos in vitro beyond the 14th day after fertilization." "We realize the scientific world will find this very restrictive," said Bjoern Elmquist, a Danish member of parliament an

Written byTor Noerretranders
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

COPENHAGEN-The use of human embryos in industry should be banned and their use in therapeutic and scientific work strongly regulated, the Parliamentary Assembly of the Council of Europe has recommended to its 22 members. Its recommendation, approved Sept. 25, calls on European governments to forbid "the maintenance of embryos in vitro beyond the 14th day after fertilization."

"We realize the scientific world will find this very restrictive," said Bjoern Elmquist, a Danish member of parliament and chairman of the Legal Affairs Committee of the European Council.

The Council recommended that governments limit the industrial use of embryos, or tissues from. them, to strictly therapeutic purposes. It would forbid research on human embryos likely to stay alive and be born, as well as experimentation on living embryos, whether viable or not. It also called for a ban on the creation of embryos in vitro for use in research and on the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies